Skip to main content

Table 5 Cardiac findings according to CMR results

From: Identification of cardiomyopathy associated circulating miRNA biomarkers in patients with muscular dystrophy using a complementary cardiovascular magnetic resonance and plasma profiling approach

  MD Normal CMR Abnormal CMR p value
N = 63 N = 14 N = 49
LV-EDVi, ml/m2 85 ± 30 72 ± 19 88 ± 32 0.08
LV-ESVi, ml/m2 41 ± 21 24 ± 7 46 ± 21 <0.0001
LV-mass, g/m2 60 ± 16 52 ± 11 62 ± 17 0.037
LV-EF, % 53 ± 12 67 ± 6 50 ± 11 <0.0001
RV-EF, % 53 ± 9 58 ± 7 52 ± 9 0.023
LV-EF <55 %, n (%) 29 (46) 0 (0) 29 (59) NA
RV-EF <45 %, n (%) 10 (16) 0 (0) 10 (20) NA
LGE presence, n (%) 48 (76) 0 (0) 48 (98) NA
LGE extent, % 7 (1–17) - 10 (4–24) NA
  1. Bold text indicates a significant p-value of <0.05